CRESCO Guest Lecture by Dr Eda Yildirim - Balancing X-chromosome dosage: Mechanistic insights and its impact on cancer

We have the pleasure of inviting you to a guest lecture titled Balancing X-chromosome dosage: Mechanistic insights and its impact on cancer by Eda Yildirim, Assistant Professor at Duke University School of Medicine, USA.

Portrait of Dr Eda Yildirim

Dr Eda Yildirim

Research synopsis of the Eda Yildirim Lab


Dr. Eda Yildirim uses mammalian X-chromosome inactivation as a model to determine how long noncoding RNA-mediated processes regulate gene expression, impact chromatin state, and participate in cell fate decisions during hematopoiesis and how alterations in these processes impact hematologic malignancies. 


Her second interest is in understanding how spatial organization of the genome and gene expression is achieved through interactions that are formed between chromatin and the components of the nuclear pore complex, called nucleoporins. 


The aim of her research is to define how chromatin associated function of nucleoporins influence epigenetic gene regulation and genome function during development and cancer. The Yildirim Lab approaches these questions by utilizing a variety of genetic, cell biological, imaging and genomics tools using mouse embryonic and adult stem cells, human cells, and mouse models.

Tags: x-chromosome, lncRNA, gene, chromatin, nucleoporins, epigenetics, cancer, embryo, stemcell
Published Mar. 19, 2024 2:09 PM - Last modified Mar. 19, 2024 2:12 PM